# IceCure Medical

Source: https://onco.cc/companies/icecure-medical/  
OnCo record `icecure-medical` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

IceCure Medical makes ProSense, a liquid-nitrogen cryoablation system used to freeze small breast, kidney, lung and bone tumours through a single needle in an outpatient visit; its ICE3 trial tested it as an alternative to surgery for small low-risk breast cancers in older women.

## Summary

IceCure Medical, founded in Israel in 2006, designed ProSense around liquid nitrogen rather than argon to reach very low probe temperatures and larger ice balls with a single thin probe, under ultrasound guidance in an office setting. The ICE3 single-arm trial followed women aged sixty and over with small low-risk breast cancers treated by cryoablation instead of lumpectomy, and the company is pursuing a breast cancer indication in the United States on those results while the system is used for kidney, lung, liver and bone tumours. OnCo links it to cryoablation and thermal ablation.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Tags: machines-wave
- HQ: Caesarea
- Type: devices
- Website: https://www.icecure-medical.com
- Ticker: ICCM

## Sources

- Official website: https://www.icecure-medical.com

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Renal cell carcinoma](https://onco.cc/cancers/rcc/)
- fronts: [Devices & Physical Therapies](https://onco.cc/fronts/devices/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Cryoablation systems](https://onco.cc/technologies/cryoablation-systems/), [Thermal ablation (RFA, microwave, cryo)](https://onco.cc/technologies/thermal-ablation/)

---
JSON: https://onco.cc/api/v1/entities/icecure-medical.json